Compare CAN & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAN | LAB |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.0M | 270.6M |
| IPO Year | 2019 | 2008 |
| Metric | CAN | LAB |
|---|---|---|
| Price | $0.21 | $0.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $1.39 | N/A |
| AVG Volume (30 Days) | ★ 5.9M | 758.2K |
| Earning Date | 11-17-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.54 |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $101,937,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $70.43 | N/A |
| P/E Ratio | ★ N/A | $2.49 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.15 | $0.62 |
| 52 Week High | $1.95 | $1.72 |
| Indicator | CAN | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 27.19 | 38.27 |
| Support Level | $0.15 | $0.63 |
| Resistance Level | $0.56 | $0.79 |
| Average True Range (ATR) | 0.02 | 0.05 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 0.07 | 5.56 |
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.